Skip to main content
. 2018 Nov 7;10(11):1697. doi: 10.3390/nu10111697

Table 2.

Levels of cardiac function after liquid ubiquinol supplementation.

Week 0 Week 12 Week 24 p Values
Echocardiography
EF (%) 62.56 ± 7.47 (63.85) 1 66.28 ± 9.78 (68.35) 65.67 ± 9.63 (66.85) 0.15
FS (%) 34.20 ± 5.22 (35.45) 37.07 ± 7.28 (38.98) 36.59 ± 6.86 (37.60) 0.19
CO (L/min) 10.77 ± 14.47 (5.83) 16.36 ± 26.16 (5.72) 14.62 ± 26.18 (5.62) 0.73
SV (mL) 159.96 ± 274.25 (72.73) 176.32 ± 217.88 (84.10) 144.40 ± 217.56 (55.96) 0.44
HR (beat/min) 82.15 ± 27.82 (85.00) 82.6 ± 33.18 (83.75) 86.50 ± 27.07 (92.00) 0.93
LVOTd (cm) 1.75 ± 0.78 (1.60) 1.87 ± 0.61 (1.80) 1.68 ± 0.63 (1.65) 0.25
EDV (mL) 133.92 ± 104.69 (107.50) 132.75 ± 99.49 (109.00) 135.16 ± 98.41 (99.20) 0.93
ESV (mL) 53.12 ± 50.17 (38.05) 48.14 ± 46.70 (33.00) 51.05 ± 48.42 (41.45) 0.15
LVIDd (cm) 5.00 ± 1.61 (4.80) 4.99 ± 1.57 (4.83) 5.05 ± 1.53 (4.64) 0.89
LVIDs (cm) 3.32 ± 1.20 (3.10) 3.17 ± 1.18 (2.92) 3.25 ± 1.21 (3.22) 0.22
CI (L/(min*m2)) 8.36 ± 8.61 (5.82) 12.15 ± 15.74 (5.60) 10.39 ± 15.71 (5.05) 0.73
MPI 0.84 ± 0.47 (0.66) 0.76 ± 0.34 (0.89) 0.75 ± 0.47 (0.70) 0.48
Hematology
BNP (pg/mL) 115.6 ± 152.2 (56.9) 157.4 ± 212.1 (48.8) 148.0 ± 217.2 (50.8) 0.63
NT-Pro BNP (pg/mL) 357.1 ± 451.6 (236.0) 527.2 ± 703.8 (365.5) 458.3 ± 694.3 (191.5) 0.23
CK (U/L) 238.0 ± 344.0 (135.5) 436.2 ± 772.7 (141.5) 181.9 ± 105.5 (141.5) 0.70
CK-MB (U/L) 14.2 ± 6.65 (16.0) 10.8 ± 6.5 (12.0) 12.6 ± 8.4 (11.0) 0.52

1 means ± standard deviations (medians). BNP, B-type natriuretic peptide; CI, cardiac index; CK, creatine kinase; CK-MB, creatine kinase-muscle/brain; CO, cardiac output; EDV, end-diastolic volume; EF, ejection fractions; ESV, end-systolic volume; FS, fractional shortening; HR, heart rate; LVIDd, left ventricular internal diameter end-diastole; LVIDs; left ventricular internal diameter end-systole; LVOTd, left ventricular outflow tract diameter; MPI, myocardial performance index; NT-Pro BNP, N-terminal pro B-type natriuretic peptide; SV, stroke volume.